Articles tagged with Biofilm Infections
Researchers at USC School of Dentistry and Viterbi School of Engineering developed a non-thermal plasma dental probe that destroys bacterial colonies and disinfects hard-to-reach areas. The tool uses pulsed power to create a room temperature plasma with antibacterial properties.
Researchers have identified the DegU protein as crucial for bacterial decision-making in biofilms. This protein enables individual bacteria to switch between different physiological processes, such as movement and biofilm production, in response to environmental conditions.
Researchers in Colorado discovered a way to disrupt Pseudomonas aeruginosa biofilm formation by targeting protein and DNA with specific enzymes. This breakthrough could lead to improved treatment strategies for infections caused by this bacteria, which are prevalent in burns, wounds, and cystic fibrosis patients.
Bacteria in biofilms evolve to become more resilient with age, resisting antibiotics and outcompeting younger cells. This study provides evidence of natural selection in a single species bacterial biofilm, offering insights into the emergence of dominant microbial populations.
Sticky glue secreted by Staphylococcus aureus bacteria may hold the key to creating an effective vaccine against MRSA. Researchers have found that manipulating this natural compound can stimulate the right immune response, offering a potential solution to the growing problem of antibiotic-resistant infections.
Scientists discovered that biofilm bacteria produce harmful chemicals, including a protein similar to rattlesnake venom, which can cause disease progression and resistance to antibiotics. This research has significant implications for the treatment of hospital superbugs, cystic fibrosis, and cancer.
MSU scientist Darla Goeres is developing standardized methods to measure the effectiveness of antimicrobial products against biofilms. This work aims to improve public trust in product efficacy claims.
Researchers at the Helmholtz Center for Infection Research discovered that biofilm bacteria use violacein, a pigment produced in response to threats, to neutralize attackers and trigger a suicide mechanism in phagocytes. This finding presents a new avenue for combating human parasites causing diseases like sleeping sickness and malaria.
Researchers at USC School of Dentistry have found a connection between bisphosphonate drugs and jaw infections, with biofilms playing a key role in the deterioration of jaw tissue. The study aims to develop effective treatments or prevention methods for osteonecrosis of the jaw.
Researchers study the function of biofilm in Bovine Respiratory Disease Complex (BRDC), a major economic problem affecting feedlot cattle. The goal is to understand how biofilms contribute to disease and develop effective vaccines.
Timothy Lu has engineered bacteriophage to boost antibiotic effectiveness, destroying bacterial defenses and enabling antibiotics to perform better. His platform also thwarts the development of stronger antibiotic resistance, extending the lifetime of existing and future antibiotic drugs.
Researchers found that biofilms composed of resistant microbial cells are the cause of corneal infections fueled by soft contact lens use. They recommend improved testing with modern fungal strains and adherence to lens care best practices.
Researchers confirm that bacteria responsible for UTIs are entrenched inside human bladder cells, contradicting previous models. The finding confirms the importance of fully understanding bacterial behavior in the bladder to develop better diagnoses and treatments.
Researchers at Stevens Institute of Technology are developing functional polymers modified surfaces that can prevent bacterial adhesion and sensitize formed biofilms for antibiotic treatment. This project aims to combat the fourth leading cause of death in the US, hospital-acquired infections and diseases.
Researchers developed a microfluidic device that reveals how bacteria organize to form antibiotic-resistant biofilms, which play key roles in cystic fibrosis and urinary tract infections. The study's findings could help develop new treatments and preventive measures for these diseases.
A new study has developed an antimicrobial approach using gallium to defeat drug-resistant bacteria. The researchers interfered with a key bacterial nutrient, killing microbes in laboratory experiments and eliminating life-threatening infections in mice.
A team at the University of Cincinnati discovered a new way to combat antibiotic-resistant bacteria by substituting gallium for iron, preventing bacterial growth and biofilm formation. This method shows promise in treating lung infections, particularly in cystic fibrosis patients.
Researchers have found a compound that can act like a bed of nails, fending off microbes from colonizing wound dressings and other implantable devices. Coating these devices with the compound could help prevent thousands of bacterial and yeast infections annually.
The National Institute of General Medical Sciences (NIGMS) will award $13 million to create four centers to develop new treatments for various types of wounds, including burns, diabetic ulcers, and bedsores. This initiative aims to deepen understanding of wound healing and apply knowledge to enhance treatment.
A groundbreaking study found that nearly all children with chronic otitis media have resistant biofilm bacteria in their middle ears, rendering antibiotics ineffective. This discovery sheds new light on the treatment of chronic ear infections and suggests alternative approaches such as probiotics.
Researchers at UT Southwestern found that MRI offers more detailed views and specific information on cochlear implants than CT scans. This enables surgeons to determine the best surgical technique, electrode arrays, and ear placement for each patient.
Researchers discovered that GroEL1 oversees production of fatty acids necessary for biofilm growth, which are absent in bacteria lacking the chaperone protein. Understanding this mechanism could lead to new ways to develop effective drugs to fight TB and other mycobacterial infections.
Researchers found that Pseudomonas aeruginosa biofilms develop faster in the presence of neutrophils, which are sent to fight infections. The biofilms become resistant to antibiotics and the immune system, leading to chronic lung damage and death.
Tap water is a significant source of hospital-acquired infections, with biofilm harbouring pathogenic microorganisms. Point-of-use 0.2 micron filters can significantly reduce the release of pathogens and aerosols, providing an absolute barrier between patients and contaminated water.
Researchers aim to control biofilm formation by manipulating quorum sensing in bacteria. They are designing new compounds that mimic natural molecules to disrupt bacterial signaling, potentially preventing hospital infections.
A recent study published in Journal of Bacteriology has identified the HipA gene responsible for making persister cells resistant to antibiotics. Biofilm infections, which can cause fatal lung infections, periodontal disease, and other serious health issues, are notoriously difficult to treat.
Researchers at the University of Iowa found that bacteria in biofilms rapidly diversify, providing a form of biological insurance against adverse conditions. This diversity increases the bacteria's capabilities and may contribute to the difficulty in eradicating chronic infections caused by biofilms.
The RetS gene product in P. aeruginosa activates virulence factors for acute infection while repressing those required for long-term, chronic infection. This system may orchestrate the transition from acute colonization to chronic infection in this human pathogen.
A study published in Nature reveals a genetic approach that may help combat antibiotic-resistant biofilms, which are involved in 65% of human bacterial infections. The researchers identified a mutant strain of Pseudomonas aeruginosa that is more sensitive to antibiotics, providing a potential solution for diseases like cystic fibrosis.
Researchers are working on developing new treatments for bioterrorism and drug resistance, including the use of bacteriophages to target specific bacteria. Understanding how microbes create biofilms is also crucial in preventing chronic infections.
Cystic fibrosis patients' lungs are infected primarily with bacterial biofilms, which are resistant to antibiotic treatment and cause damage to the lungs. A new test developed by University of Iowa researchers shows that Pseudomonas aeruginosa produces signaling molecules indicative of a biofilm state.
Biofilm bacteria are a common cause of persistent infections, such as ear infections and cystic fibrosis pneumonia. Recent advances in understanding biofilms may help develop new therapeutic agents to control these infections.
A team of microbiologists genetically altered Pseudomonas aeruginosa to break its resistance to detergents and antibiotics. The study found that disabling the lasI gene reduced the bacteria's ability to form deadly biofilms.
Researchers have identified a key chemical message that triggers the formation of biofilms, complex communities of bacteria that are notoriously resistant to antibiotics. This discovery could lead to the development of more effective treatments for bacterial infections.
Researchers at MSU and elsewhere find chemical language that governs biofilm formation and destruction, enabling potential control through disrupting natural messaging system. This discovery has implications for treating chronic infections and improving biofilm management.